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Case report

Mycobacterium chimaera infection masquerading as a lung mass in a
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Mycobacterium chimaera, a nontuberculous mycobacterium, is a member of the Mycobacterium avium
complex (MAC). This microorganism has recently gained signiﬁcant notoriety for its association with
outbreaks in patients exposed to contaminated heater –cooler devices used during open heart surgeries.
We report a case of Mycobacterium chimaera pulmonary infection in a healthcare worker who
presented with cough, low grade fever and weight loss with evidence of a lung mass that was initially
thought to be a tumor on CT scan imaging. The patient underwent partial left lung lobectomy and
pathology revealed necrotizing granulomas with acid fast bacilli and a culture grew M. chimaera. The
patient received combination antimycobacterial therapy according to susceptibility results for twelve
months with complete resolution of his symptoms and radiographic ﬁndings.
Infection Control investigation could not ﬁnd a source of infection in the hospital where he worked
during the last ten years. However, the patient rotated in different hospitals before coming to work at this
facility and assisted in surgeries in several operating rooms where the heater-cooler devices in question
were used.
© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Case report
A 66-year-old Caucasian male Physician Assistant was evaluated
at the Infectious Disease clinic for ten-pound weight loss and
worsening dry cough without fevers, night sweats or hemoptysis. He
had a history of controlled type 2 diabetes mellitus, hypertension,
dyslipidemia and remote history of latent tuberculosis treated in
1973 with 6 months of isoniazid. He smoked one pack of cigarettes
per day during his early adulthood and quit smoking more than 40
years ago. On examination, he appeared weak and anxious with a
weight 83 kg that appeared appropriate for his 185-cm height. He
had a normal respiratory rate of 16 per minute, pulse of 78 per
minute, and a blood pressure of 127/76 mmHg. Chest auscultation
revealed good breath sounds with few left upper lobe rhonchi
without crackles. The remainder of his exam was normal. Laboratory
work-up revealed a white blood cell count of 5600/mm3, with 53.2%
neutrophils, 29.2% lymphocytes, 11.9% monocytes, 3.8% eosinophils,
hemoglobin 14.3 g/dL and platelet count 219,000/mm [3]. The
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comprehensive metabolic panel was within normal limits and his
HIV 1/2 antibody screen was negative.
Chest CT scan showed left upper lung lobe mass measuring
3.1  2.6  2.2 cm with smaller lower lobe lung nodules and mild
left hilar adenopathy (Fig. 1). PET scan followed with ﬁndings
concerning for malignancy. However, CT guided FNA biopsy was
done and showed no evidence of malignant cells with negative
routine, fungal and mycobacterial cultures. The patient was
referred to cardiothoracic surgery and underwent thoracotomy
and partial lobectomy with resection of the lung mass. Pathology
exam revealed necrotizing granuloma with acid fast bacilli (Fig. 2).
Mycobacterial culture grew Mycobacterium chimaera. Conﬁrmation and susceptibility testing were completed at the National
Jewish Medical Center Mycobacteriology Laboratory in Denver, CO
with molecular probes using 16S rDNA sequencing and rpoB
sequencing. The isolate showed susceptibility/ intermediately
susceptibility to clarithromycin, rifabutin and ethambutol with
minimum inhibitory concentrations of 4 mcg/ mL, 0.5 mcg/ mL and
8mcg/mL, respectively. It showed resistance to ciproﬂoxacin,
moxiﬂoxacin, linezolid and amikacin with minimum inhibitory
concentrations of 16 mcg/mL, 4 mcg/mL, 64 mcg/mL and 16mcg/
mL, respectively.
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Fig. 1. Initial CT scan of the chest showing left lung mass (arrow), nodules and hilar
adenopathy (arrowheads).

The patient was initially treated with a 3-drug regimen
including Rifabutin, Clarithromycin and Ethambutol. He had
gastrointestinal intolerance to Clarithromycin, and it had to be
switched to Azithromycin after 2 months. He also developed an
allergic reaction to Rifabutin 6 months into therapy in the form of
drug fever and eosinophilia and the drug had to be stopped. He
completed the remaining 12 months of antimycobacterial therapy
with Azithromycin and Ethambutol with complete resolution of
his clinical and radiologic manifestations.
Discussion
The development of more advanced and specialized molecular
techniques for identiﬁcation of previously unrecognized organisms has permitted the isolation of many nontuberculous
mycobacteria (NTM) as human pathogens. Additionally, there
has been an increasing understanding of the defects in lung
structure and immune response that facilitates these infections
[1]. Mycobacterium chimaera (M. chimaera) is a slow-growing acidfast bacillus that forms unpigmented colonies. It was ﬁrst isolated
in 2004 as a unique subspecies pathogen from the Mycobacterium
avium complex (MAC) that also includes Mycobacterium avium and
Mycobacterium intracellulare among others [2]. Utilization of
molecular probes with 16S rDNA sequencing and rpoB sequencing
is essential to identify M. chimaera among other members of the
Mycobacterium avium complex [6,10].
Interest in M. chimaera infectious potential has emerged in the
recent few years as cardiac, pulmonary and disseminated
infections have been reported in patients with a history of
different types of cardiac surgeries. The source of infection has

been identiﬁed to be LivaNova PLC (formerly Sorin Group
Deutschland GmbH) Stöckert 3 T heater-cooler devices, used
during many of these surgeries. Some of these devices are thought
to have been contaminated during manufacturing. M. chimaera was
isolated from the water tanks within these heater-cooler devices
[3–5]. Droplets loaded with M. chimaera are ejected from the
contaminated water tanks within these devices, spreading an
infective bioaerosol with a particle size of < 1 mm in the operating
room environment. These aerosolized droplets maybe inhaled by
the patient or staff and they may also settle on surfaces forming
bioﬁlms in the operating room environment or in the patients
having surgeries that involve placement of prosthetic material
such as heart valves or vascular grafts [5,6,13–15].
M. chimaera growth and disease in patients are slow. Marra et al
reviewed 52 patients who developed M. chimaera infection
complicating cardiovascular surgeries. They identiﬁed a period
from exposure to clinical presentation up to 6 years. Patients may
present with nonspeciﬁc systemic symptoms such as fatigue, fever,
sweats, and weight loss. Pulmonary symptoms include chronic
cough and dyspnea [16]. Tissue specimens submitted for pathology
exam usually reveal noncaseating granulomas that are rarely acid
–fast bacilli smear- positive [17]. Patients may develop pulmonary
infection, locally invasive infection with involvement of sternal
wounds, mediastinum, and pleural space, prosthetic valve infection with endocarditis, vascular graft infection, or disseminated
infection with involvement of the liver, spleen, kidneys, joints,
bones and bone marrow [3–6]. Patients with prosthetic valve
infection and disseminated infection may have increased mortality
up to 50% [3,7,8,11].
The American Thoracic Society (ATS) and the Infectious Disease
Society of America (IDSA), recommend combination antimycobacterial therapy with clarithromycin, rifampin and ethambutol
for patients with disseminated Mycobacterium avium complex
infection [9]. Speciﬁc treatment regimens for patients with M.
chimaera infection have not been recommended and will need to
be outlined based on future clinical outcomes. As with other
Mycobacterium avium complex species, M. chimaera infection is
usually treated with a prolonged course of Clarithromycin,
Ethambutol, and Rifampin. Severe disease may require additional
antibiotic therapy with aminoglycosides [12].
Our patient likely contracted his M. chimaera in healthcare
facilities where he rotated and worked in their operating rooms
prior to being recruited in our facility. During his ten-year work
history at our facility, he provided patient care in a pre-operative
clinic without attending any operating rooms. Furthermore, our
facility has not provided open heart surgeries and never carried
above named heater-cooler devices that are potentially contaminated. However, we veriﬁed that the other facilities where the
patient worked in their operating rooms before ten years provided
open heart surgeries and used the heater-cooler devices in question.

Fig. 2. Left; Lung Mass Tissue Biopsy with H&E stain showing necrotizing granuloma is present on a ﬁbrotic background. Right; Lung Mass Tissue Biopsy with AFB stain,
showing Acid fast bacilli present within scattered histiocytes.
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To our knowledge, this is the ﬁrst case report of M. chimaera in a
healthcare worker with a long incubation period reﬂecting the
nature of M. chimaera slow growth and documenting M. chimaera
as potential etiology of disease in healthcare workers exposed to
bioaerosols emitted from contaminated Heater-Cooler devices
during open heart surgery.
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